Abstract:Psoriasis is a chronic inflammatory cutaneous disorder of multifactorial etiology, influenced by both genetic and environmental factors such as infection (Nestle et al., 2009Nestle F.O. Kaplan D.H. Barker J. Psoriasis.N Engl J Med. 2009; 361: 496-509Crossref PubMed Scopus (1950) Google Scholar), especially bacterial infection (England et al., 1997England R.J. Strachan D.R. Knight L.C. Streptococcal tonsillitis and its association with psoriasis: a review.Clin Otolaryngol Allied Sci. 1997; 22: 532-535Crossref PubMed Scopus (17) Google Scholar; Brown et al., 2000Brown D.W. Baker B.S. Ovigne J.M. et al.Skin CD4+ T cells produce interferon-gamma in vitro in response to streptococcal antigens in chronic plaque psoriasis.J Invest Dermatol. 2000; 114: 576-580Abstract Full Text Full Text PDF PubMed Scopus (44) Google Scholar; Gudjonsson et al., 2003Gudjonsson J.E. Thorarinsson A.M. Sigurgeirsson B. et al.Streptococcal throat infections and exacerbation of chronic plaque psoriasis: a prospective study.Br J Dermatol. 2003; 149: 530-534Crossref PubMed Scopus (160) Google Scholar; El-Rachkidy et al., 2007El-Rachkidy R.G. Hales J.M. Freestone P.P. et al.Increased blood levels of IgG reactive with secreted Streptococcus pyogenes proteins in chronic plaque psoriasis.J Invest Dermatol. 2007; 127: 1337-1342Abstract Full Text Full Text PDF PubMed Scopus (20) Google Scholar). Specifically, streptococcal DNA was found to be involved in psoriasis development. The proliferation of peripheral blood mononuclear cells (PBMCs), activation of T cells, and interferon-a (IFN-a) secretion by PBMCs were attenuated after stimulation of non-NASA (non-nucleic acid streptococcal antigen, non-NASA). The attenuated T-cell activation and IFN-a secretion in psoriatic patients could be reconstituted when stimulated by non-NASA combined with synthetic CpG-A (CpG-A is synthetic ODN containing CpG motifs and activate pDC; Cai et al., 2009Cai Y.H. Lu Z.Y. Shi R.F. et al.Enhanced proliferation and activation of peripheral blood mononuclear cells in patients with psoriasis vulgaris mediated by streptococcal antigen with bacterial DNA.J Invest Dermatol. 2009; 129: 2653-2660Abstract Full Text Full Text PDF PubMed Scopus (11) Google Scholar). At the same time, a single-nucleotide polymorphism (SNP) rs1713239 ((interleukin (IL)-20)-1723 C->G) was found to be associated with psoriatic patients, especially those patients triggered or acerbated by upper respiratory tract infection (Chen et al., 2011Chen X.Y. Jin L.W. Chen Y.W. et al.The association between the IL-20-1723C—>G allele on the 1q chromosome and psoriasis triggered or exacerbated by an upper respiratory tract infection in the Chinese Han population.Dermatology. 2011; 222: 24-30Crossref PubMed Scopus (9) Google Scholar). We recently found potential synergy between this SNP rs1713239 and CpG-A or IL-1β in regulating the transcriptional activity of the IL-20 promoter, which enhances IL-20 expression further. We found that patients carrying the G allele produced more IL-20 upon CpG-A or IL-1β stimulation, compared with the ones carrying the C allele (Wang et al., 2013Wang L.Q. Li K.J. Xu Q.N. et al.Potential synergy between SNP and CpG-A or IL-1β in regulating transcriptional activity of IL-20 promoter.J Invest Dermatol. 2013; 134: 389-395Abstract Full Text Full Text PDF PubMed Scopus (3) Google Scholar). In the process of investigating the pathogenesis of psoriasis, we found that dermal γδ T cells rather than Th17 cells was the main source of IL-17 in the skin upon IL-23 stimulation, and this process needs IL-1β. IL-23 was produced by dendritic cells and macrophages upon stimulation by the microbial products (Cai et al., 2011Cai Y.H. Shen X.Y. Ding C.L. et al.Pivotal Role of Dermal IL-17-Producing gd T Cells in Skin Inflammation.Immunity. 2011; 35: 596-610Abstract Full Text Full Text PDF PubMed Scopus (607) Google Scholar). Based on these findings, we proposed skin targeting therapy. The treatment aims at protecting the integrity of the epidermis in order to minimize disease exacerbation, which results from the activation of subcutaneous inflammatory cells due to skin damage. Our research found that by reinforcing barrier protection, psoriasis patients had significant increase in their normal and lesional skin electrical capacitance, decrease in lesion transepidermal water loss, and psoriasis area and severity index scores. More importantly, the relapse rate in these patients was lower than in controls. Skin electrical capacitance, decrease in lesional transepidermal water loss, and psoriasis area and severity index score decreases soon after topical steroid treatment, but the index returned to the baseline after long-term usage of steroid. The authors state no conflict of interest. This work was supported by the National Natural Science Foundation of China (30872278 and 81171500) and the Science and Technology Commission Foundation of Shanghai, 2011 (11JC1407500). We are most grateful to all the patients who have willingly participated in this study.

Innate lymphoid cell-based immunomodulatory hydrogel microspheres containing Cutibacterium acnes extracellular vesicles for the treatment of psoriasis

Gut Commensal Bacteria Parabacteroides Goldsteinii-Derived Outer Membrane Vesicles Suppress Skin Inflammation in Psoriasis

Engineering extracellular vesicles with macrophage membrane fusion for ameliorating imiquimod-induced psoriatic skin inflammation

Engineering extracellular vesicles with macrophage membranes fusion ameliorated psoriatic skin inflammation in imiquimod‐treated mice

Curcumin-Based Ionic Liquid Hydrogel for Topical Transdermal Delivery of Curcumin To Improve Its Therapeutic Effect on the Psoriasis Mouse Model

Efficient Treatment of Psoriasis Using Conditioned Media from Mesenchymal Stem Cell Spheroids Cultured to Produce Transforming Growth Factor- β 1-Enriched Small-Sized Extracellular Vesicles

Microneedles Loaded with Dexamethasone and Epigallocatechin‐3‐gallate Reverse the Imbalance of Subcutaneous Immune Homeostasis for the Treatment of Psoriasis

The Extracellular Vesicles from the Commensal Staphylococcus Epidermidis ATCC12228 Strain Regulate Skin Inflammation in the Imiquimod-Induced Psoriasis Murine Model

Percutaneous Delivery of Hederacoside C-Loaded Nanoliposome Gel Alleviates Psoriasiform Skin Inflammation through the CCL17/Treg Axis

Light-activated Extracellular Matrix Microcarriers with Engineered MSCs Loading for Autoimmune Psoriasis Treatment

Infection: an Important Role in the Pathogenesis of Psoriasis

Therapeutic Effect of Lecigel, Cetiol®CC, Activonol-6, Activonol-M, 1,3-Propanediol, Soline, and Fucocert® (LCAA-PSF) Treatment on Imiquimod-Induced Psoriasis-Like Skin in Mice

The Role of Extracellular Vesicles in the Development and Treatment of Psoriasis: Narrative Review

A roadmap from research to clinical testing of mesenchymal stromal cell exosomes in the treatment of psoriasis

Keratinocyte-to-macrophage communication exacerbate psoriasiform dermatitis via LRG1-enriched extracellular vesicles

Cellular nanovesicles with bioorthogonal targeting enhance photodynamic/photothermal therapy in psoriasis

Potential Pathogenetic Role of Antimicrobial Peptides Carried by Extracellular Vesicles in an in vitro Psoriatic Model

Paenibacillus exopolysaccharide alleviates Malassezia-induced skin damage: Enhancing skin barrier function, regulating immune responses, and modulating microbiota

Dissolvable hyaluronic acid microneedles loaded with -Elemene for the treatment of psoriasis

Targeting S. aureus Extracellular Vesicles: A New Putative Strategy to Counteract Their Pathogenic Potential

Development of a Deep Eutectic Solvent-Assisted Kaempferol Hydrogel: A Promising Therapeutic Approach for Psoriasis-like Skin Inflammation